Medicamen Biotech Ltd.

₹412.8

Medicamen Biotech Ltd.

  • NSE : MEDICAMEQ

₹412.8

₹412.8

-3.55 (-0.85%) - 1 Jul 2025 04:28 PM
  • NSE : MEDICAMEQ

About Company

Medicamen Biotech Limited is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. It is a manufacturer and supplier of a range of products, such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum), and ointment. Its product offerings include Acarbrose Tablets 50 milligram, Acetazolamide Tablet 250 milligram BP, Amitriptyline Hcl Tablet 25 milligram, Amlodipine Besylate Tablet 10 milligram, and Sulfadoxine and Anti Malarial Kit. As of March 31, 2012, its production capacity under beta lactum included tablets (eight million per day), capsules (one million per day), oral liquid (4600 liters per day), and dry syrup (6000 kilogram per day). Its production capacity under non beta lactum included tablets (one million per day), capsules (one million per day), liquid (1300 liters per day), and dry syrup (50,000 bottles per day). The Company has two manufacturing at Bhiwadi and Haridwar.

Market Cap. ₹ 565 Cr.
52 Week - High/Low ₹ 630/375
P/E Ratio 55.96
P/B Ratio 2.70
Enterprise Value ₹ 564 Cr.
ROE % 6.85
RSI Value 56.61
EMA 50 430.39
EMA 200 467.63
Market Cap. ₹ 565 Cr.
52 Week - High/Low ₹ 630/375
P/E Ratio 60.87
P/B Ratio 2.73
Enterprise Value ₹ 567 Cr.
ROE % 4.94
RSI Value 56.61
EMA 50 430.39
EMA 200 467.63

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.